Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Treating ADHD in Prison: Focus on Alpha-2 Agonists (Clonidine and Guanfacine).

Mattes JA.

J Am Acad Psychiatry Law. 2016 Jun;44(2):151-7.

PMID:
27236168
2.

Right versus left hippocampal activity as a biomarker in schizophrenia.

Mattes JA.

Am J Psychiatry. 2014 Sep;171(9):1000-1. doi: 10.1176/appi.ajp.2014.14050687. No abstract available.

PMID:
25178755
3.

Medications for aggressiveness in prison: focus on oxcarbazepine.

Mattes JA.

J Am Acad Psychiatry Law. 2012;40(2):234-8.

PMID:
22635296
4.

Bipolar disorder?

Mattes JA.

Arch Gen Psychiatry. 2010 Nov;67(11):1198. doi: 10.1001/archgenpsychiatry.2010.143. No abstract available.

PMID:
21041621
5.

Suggested improvements to the overt aggression scale-modified.

Mattes JA.

J Neuropsychiatry Clin Neurosci. 2010 Winter;22(1):123.E1; discussion 123.E2. doi: 10.1176/appi.neuropsych.22.1.123.e1. No abstract available.

PMID:
20160220
6.

Questionable efficacy for naltrexone in patients with Asp40.

Mattes JA.

Arch Gen Psychiatry. 2009 Jul;66(7):796; author reply 796-7. doi: 10.1001/archgenpsychiatry.2009.68. No abstract available.

PMID:
19581571
7.

High-dose olanzapine versus clozapine.

Mattes JA.

J Clin Psychiatry. 2008 Oct;69(10):1660; author reply 1660-1. No abstract available.

PMID:
19192450
8.
9.

Understanding schizophrenia.

Mattes JA.

Am J Psychiatry. 2007 Sep;164(9):1438. No abstract available.

PMID:
17728434
10.

Antabuse reaction with ceftin.

Mattes JA.

Am J Psychiatry. 2006 Nov;163(11):2019-20. No abstract available.

PMID:
17074964
11.

Less mood switching with venlafaxine?

Mattes JA.

Am J Psychiatry. 2006 Sep;163(9):1642; author reply 1642-3. No abstract available.

PMID:
16946194
12.

Antidepressant-induced rapid cycling: another perspective.

Mattes JA.

Ann Clin Psychiatry. 2006 Jul-Sep;18(3):195-9. Review.

PMID:
16923658
13.
14.

Irritability and depression.

Mattes JA.

Am J Psychiatry. 2005 May;162(5):1025; author reply 1025. No abstract available.

PMID:
15863822
15.

Evidence-based promotion.

Mattes JA.

Am J Psychiatry. 2004 Oct;161(10):1928; author reply 1929. No abstract available.

PMID:
15466002
16.
17.

Mood improvement from transcranial magnetic stimulation.

Mattes JA.

Am J Psychiatry. 1999 Apr;156(4):669; author reply 669-70. No abstract available.

PMID:
10200769
18.

Fluoxetine and norfluoxetine.

Mattes JA.

Am J Psychiatry. 1998 Nov;155(11):1637. No abstract available.

PMID:
9812147
19.

Sertindole versus haloperidol for schizophrenia.

Mattes JA.

Am J Psychiatry. 1998 Sep;155(9):1303; author reply 1303-4. No abstract available.

PMID:
9734567
20.

Stroke resulting from a rapid switch from phenelzine to tranylcypromine.

Mattes JA.

J Clin Psychiatry. 1998 Jul;59(7):382. No abstract available.

PMID:
9714269
21.

Olanzapine on trial.

Mattes JA.

Am J Psychiatry. 1998 Jan;155(1):153; author reply 153-5. No abstract available.

PMID:
9433359
22.

Brain serotonin neurotoxicity and fenfluramine and dexfenfluramine.

Mattes JA.

JAMA. 1997 Dec 24-31;278(24):2141; author reply 2142. No abstract available.

PMID:
9417001
23.

Patent laws: could changes enhance drug development?

Mattes JA.

Arch Gen Psychiatry. 1997 Oct;54(10):970. No abstract available.

PMID:
9337779
24.

Can the sensitivity of the Alzheimer's Disease Assessment Scale be increased?

Mattes JA.

Am J Geriatr Psychiatry. 1997 Summer;5(3):258-60.

PMID:
9209568
25.
26.

Risperidone: how good is the evidence for efficacy?

Mattes JA.

Schizophr Bull. 1997;23(1):155-61. Review.

PMID:
9050121
27.

Low rate of Alzheimer's disease in Nigeria.

Mattes JA.

Am J Psychiatry. 1996 Dec;153(12):1654-5. No abstract available.

PMID:
8942472
28.

Driving and Alzheimer disease.

Mattes JA.

JAMA. 1996 Jan 17;275(3):182; author reply 182-3. No abstract available.

PMID:
8604162
29.

Fluvoxamine in obsessive-compulsive nonresponders to clomipramine or fluoxetine.

Mattes JA.

Am J Psychiatry. 1994 Oct;151(10):1524. No abstract available.

PMID:
8092352
30.
31.

Should DSM-III-R GAD criteria be used for studies of anxiolytics?

Mattes JA, Konig PH.

Biol Psychiatry. 1993 Feb 15;33(4):302-3. Review. No abstract available.

PMID:
8097116
32.

Valproic acid for nonaffective aggression in the mentally retarded.

Mattes JA.

J Nerv Ment Dis. 1992 Sep;180(9):601-2. No abstract available.

PMID:
1522412
33.

MAOIs and Ménière's syndrome.

Mattes JA.

Am J Psychiatry. 1990 Apr;147(4):534. No abstract available.

PMID:
2316744
34.

A placebo-controlled evaluation of vasopressin for ECT-induced memory impairment.

Mattes JA, Pettinati HM, Stephens S, Robin SE, Willis KW.

Biol Psychiatry. 1990 Feb 1;27(3):289-303.

PMID:
2405915
35.

A controlled family study of adopted patients with temper outbursts.

Mattes JA, Fink M.

J Nerv Ment Dis. 1990 Feb;178(2):138-9. No abstract available.

PMID:
2299338
36.

Comparative effectiveness of carbamazepine and propranolol for rage outbursts.

Mattes JA.

J Neuropsychiatry Clin Neurosci. 1990 Spring;2(2):159-64.

PMID:
2136070
37.
38.

Vasopressin for ECT-induced memory impairment: a placebo-controlled comparison.

Mattes JA, Pettinati HM, Nilsen SM, Robin SE, Willis KW.

Psychopharmacol Bull. 1989;25(1):80-4. No abstract available.

PMID:
2772120
39.

Methylphenidate and growth in hyperactive children. A controlled withdrawal study.

Klein RG, Landa B, Mattes JA, Klein DF.

Arch Gen Psychiatry. 1988 Dec;45(12):1127-30.

PMID:
3058088
40.

A controlled evaluation of a JCAH regulation.

Mattes JA.

Psychiatr Hosp. 1987 Summer;18(3):131-4.

PMID:
10289831
41.

Carbamazepine vs. propranolol for rage outbursts.

Mattes JA.

Psychopharmacol Bull. 1988;24(1):179-82. No abstract available.

PMID:
3290939
42.

A family study of patients with temper outbursts.

Mattes JA, Fink M.

J Psychiatr Res. 1987;21(3):249-55.

PMID:
3681760
43.

Propranolol for adults with temper outbursts and residual attention deficit disorder.

Mattes JA.

J Clin Psychopharmacol. 1986 Oct;6(5):299-302.

PMID:
3771813
44.

Psychopharmacology of temper outbursts. A review.

Mattes JA.

J Nerv Ment Dis. 1986 Aug;174(8):464-70. Review.

PMID:
3525749
45.

A pilot study of combined trazodone and tryptophan in obsessive-compulsive disorder.

Mattes JA.

Int Clin Psychopharmacol. 1986 Apr;1(2):170-3.

PMID:
3571943
46.

Side effects of the new antidepressants.

Mattes JA.

Am J Psychiatry. 1986 Feb;143(2):261. No abstract available.

PMID:
3946674
47.

Dysthymia and attention deficit disorder in adults.

Mattes JA.

Am J Psychiatry. 1986 Jan;143(1):114-5. No abstract available.

PMID:
3942264
48.

Ceruletide for schizophrenia: a review.

Mattes JA, Hom W, Rochford JM.

Psychopharmacol Bull. 1986;22(1):119-22. Review. No abstract available.

PMID:
3523571
49.

A high-dose, double-blind study of ceruletide in the treatment of schizophrenia.

Mattes JA, Hom W, Rochford JM.

Am J Psychiatry. 1985 Dec;142(12):1482-4.

PMID:
3907376
50.

Methylphenidate in mild depression: a double-blind controlled trial.

Mattes JA.

J Clin Psychiatry. 1985 Dec;46(12):525-7.

PMID:
3905773

Supplemental Content

Loading ...
Support Center